FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 1771305 · Received July 27, 2010

Report

Report Number
2124215-2010-12287
Event Type
Injury
Date Received
July 27, 2010
Date of Event
June 7, 2010
Report Date
June 7, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT OF THIS OBSERVATION. A REQUEST HAS BEEN MADE TO HAVE THESE PRODUCT RETURNED TO BOSTON SCIENTIFIC. THIS EVENT WILL BE UPDATED IF ANY ADDITIONAL INFORMATION BECOMES AVAILABLE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT'S ENTIRE SYSTEM WAS EXPLANTED DUE TO AN INFECTION. EXPLANTED PRODUCTS INCLUDED AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD), TRANSVENOUS RIGHT VENTRICULAR (RV) RATE/SENSE AND DEFIBRILLATION LEADS, AND A TRANSVENOUS RIGHT ATRIAL (RA) LEAD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 68 YR Life Threatening| R 0158| 4035| E110| 4469| 1298| A155